PPAR-γ Activation Prevents Septic Cardiac Dysfunction via Inhibition of Apoptosis and Necroptosis.
PPAR-γ Activation Prevents Septic Cardiac Dysfunction via Inhibition of Apoptosis and Necroptosis.
复制标题
PPAR-gamma 激活通过抑制细胞凋亡和坏死性凋亡来预防脓毒性心脏功能障碍
DOI:
10.1155/2017/8326749
复制
发表时间:
2017
影响因子:
--
通讯作者:
Xiao F
中科院分区:
文献类型:
--
作者:
Peng S;Xu J;Ruan W;Li S;Xiao F
Sepsis-induced cardiac dysfunction remains one of the major causes of death in intensive care units. Overwhelmed inflammatory response and unrestrained cell death play critical roles in sepsis-induced cardiac dysfunction. Peroxisome proliferator-activated receptor- (PPAR-) γ has been proven to be cardioprotective in sepsis. However, the mechanism of PPAR-γ-mediated cardioprotection and its relationship with inflammation and cell death are unclear. We hypothesized that activation of PPAR-γ by reducing cardiac inflammation, myocardial apoptosis, and necroptosis may prevent myocardial dysfunction in sepsis. Rats were subjected to cecal ligation and puncture (CLP) with or without PPAR-γ agonist (rosiglitazone) or antagonist T0070907 (T007). After CLP, cardiac function was significantly depressed, which was associated with the destructed myocardium, upregulated proinflammatory cytokines, and increased apoptosis, necrosis, and necroptosis. This process is corresponded with decreased inhibitor κB (IκBα) and increased NF-κB, receptor-interacting protein kinase-1 (RIP1), RIP3, and mixed lineage kinase-like (MLKL) protein. Activation of PPAR-γ by rosiglitazone pretreatment enhanced PPAR-γ activity and prevented these changes, thereby improving the survival of septic rats. In contrast, inhibition of PPAR-γ by T007 further exacerbated the condition, dropping the survival rate to nearly 0%. In conclusion, PPAR-γ activation by reducing proinflammatory cytokines, apoptosis, and necroptosis in the myocardium prevents septic myocardial dysfunction.
登录
查看更多内容
DOI:
10.1097/shk.0000000000000520
发表时间:
2016-04
期刊:
Shock (Augusta, Ga.)
影响因子:
--
作者:
Araújo CV;Campbell C;Gonçalves-de-Albuquerque CF;Molinaro R;Cody MJ;Yost CC;Bozza PT;Zimmerman GA;Weyrich AS;Castro-Faria-Neto HC;Silva AR
通讯作者:
Silva AR
影响因子:
30.3
作者:
Nogusa S;Thapa RJ;Dillon CP;Liedmann S;Oguin TH 3rd;Ingram JP;Rodriguez DA;Kosoff R;Sharma S;Sturm O;Verbist K;Gough PJ;Bertin J;Hartmann BM;Sealfon SC;Kaiser WJ;Mocarski ES;López CB;Thomas PG;Oberst A;Green DR;Balachandran S
通讯作者:
Balachandran S
影响因子:
3.2
作者:
Kaplan J;Nowell M;Chima R;Zingarelli B
通讯作者:
Zingarelli B
影响因子:
3.7
作者:
Furian, Thiago;Aguiar, Cyntia;Biolo, Andreia
通讯作者:
Biolo, Andreia
DOI:
10.1161/circheartfailure.112.000177
发表时间:
2013-05
期刊:
Circulation. Heart failure
影响因子:
--
作者:
Drosatos K;Khan RS;Trent CM;Jiang H;Son NH;Blaner WS;Homma S;Schulze PC;Goldberg IJ
通讯作者:
Goldberg IJ